The DOI matches its Crossref record; 112 of the 112 references it cites were found in a registry or an index.
Beyond TGFβ: roles of other TGFβ superfamily members in cancer
Open accessAbstract
Much of the focus on the transforming growth factor-β (TGFβ) superfamily in cancer has revolved around the TGFβ ligands themselves. However, it is now becoming apparent that deregulated signalling by many of the other superfamily members also has crucial roles in both the development of tumours and metastasis. Furthermore, these signalling pathways are emerging as plausible therapeutic targets. Their roles in tumorigenesis frequently reflect their function in embryonic development or in adult tissue homeostasis, and their influence extends beyond the tumours themselves, to the tumour microenvironment and more widely to complications of cancer such as cachexia and bone loss.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Mechanisms of TGF-β Signaling from Cell Membrane to the Nucleus
Shi, Y., & Massagué, J. (2003) · Cell · doi:10.1016/s0092-8674(03)00432-x · Cited by 5,857
Transitions between epithelial and mesenchymal states: acquisition of malignant and stem cell traits
Polyak, K., & Weinberg, R. A. (2009) · Nature Reviews Cancer · doi:10.1038/nrc2620 · Cited by 3,302
Massagué, J. (2012) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm3434 · Cited by 3,128
Targeting the TGFβ signalling pathway in disease
Akhurst, R. J., & Hata, A. (2012) · Nature Reviews Drug Discovery · doi:10.1038/nrd3810 · Cited by 1,466
TGFβ–SMAD signal transduction: molecular specificity and functional flexibility
Schmierer, B., & Hill, C. S. (2007) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2297 · Cited by 1,271
Self-citationEpidermal homeostasis: a balancing act of stem cells in the skin
Blanpain, C., & Fuchs, E. (2009) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2636 · Cited by 1,270
Bone morphogenetic proteins inhibit the tumorigenic potential of human brain tumour-initiating cells
Piccirillo, S. G. M., Reynolds, B. A., Zanetti, N., Lamorte, G., Binda, E., Broggi, G., Brem, H., Olivi, A., Dimeco, F., & Vescovi, A. L. (2006) · Nature · doi:10.1038/nature05349 · Cited by 1,176
Cancer Stem Cells: Impact, Heterogeneity, and Uncertainty
Magee, J. A., Piskounova, E., & Morrison, S. J. (2012) · Cancer Cell · doi:10.1016/j.ccr.2012.03.003 · Cited by 1,101
Tsai, J. H., Donaher, J. L., Murphy, D. A., Chau, S., & Yang, J. (2012) · Cancer Cell · doi:10.1016/j.ccr.2012.09.022 · Cited by 1,071
He, X. C., Zhang, J., Tong, W.-G., Tawfik, O., Ross, J., Scoville, D. H., Tian, Q., Zeng, X., He, X., Wiedemann, L. M., et al. (2004) · Nature Genetics · doi:10.1038/ng1430 · Cited by 1,065
Bone morphogenetic protein receptors and signal transduction
Miyazono, K., Kamiya, Y., & Morikawa, M. (2010) · Journal of Biochemistry · doi:10.1093/jb/mvp148 · Cited by 999
Ocaña, O. H., Córcoles, R., Fabra, Á., Moreno-Bueno, G., Acloque, H., Vega, S., Barrallo-Gimeno, A., Cano, A., & Nieto, M. A. (2012) · Cancer Cell · doi:10.1016/j.ccr.2012.10.012 · Cited by 973
Samavarchi-Tehrani, P., Golipour, A., David, L., Sung, H.-K., Beyer, T. A., Datti, A., Woltjen, K., Nagy, A., & Wrana, J. L. (2010) · Cell Stem Cell · doi:10.1016/j.stem.2010.04.015 · Cited by 943
Reversal of Cancer Cachexia and Muscle Wasting by ActRIIB Antagonism Leads to Prolonged Survival
Zhou, X., Wang, J. L., Lu, J., Song, Y., Kwak, K. S., Jiao, Q., Rosenfeld, R., Chen, Q., Boone, T., Simonet, W. S., et al. (2010) · Cell · doi:10.1016/j.cell.2010.07.011 · Cited by 940
Induction of Cachexia in Mice by Systemically Administered Myostatin
Zimmers, T. A., Davies, M. V., Koniaris, L. G., Haynes, P., Esquela, A. F., Tomkinson, K. N., McPherron, A. C., Wolfman, N. M., & Lee, S.-J. (2002) · Science · doi:10.1126/science.1069525 · Cited by 907
Paracrine and Autocrine Signals Induce and Maintain Mesenchymal and Stem Cell States in the Breast
Scheel, C., Eaton, E. N., Li, S. H.-J., Chaffer, C. L., Reinhardt, F., Kah, K.-J., Bell, G., Guo, W., Rubin, J., Richardson, A. L., et al. (2011) · Cell · doi:10.1016/j.cell.2011.04.029 · Cited by 858
Making a commitment: cell lineage allocation and axis patterning in the early mouse embryo
Arnold, S. J., & Robertson, E. J. (2009) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2618 · Cited by 816
De Novo Crypt Formation and Juvenile Polyposis on BMP Inhibition in Mouse Intestine
Haramis, A.-P. G., Begthel, H., van den Born, M., van Es, J., Jonkheer, S., Offerhaus, G. J. A., & Clevers, H. (2004) · Science · doi:10.1126/science.1093587 · Cited by 796
TGF-β Superfamily Signaling in Embryonic Development and Homeostasis
Wu, M. Y., & Hill, C. S. (2009) · Developmental Cell · doi:10.1016/j.devcel.2009.02.012 · Cited by 746
Self-citationActivin Receptor-like Kinase (ALK)1 Is an Antagonistic Mediator of Lateral TGFβ/ALK5 Signaling
Goumans, M.-J., Valdimarsdottir, G., Itoh, S., Lebrin, F., Larsson, J., Mummery, C., Karlsson, S., & ten Dijke, P. (2003) · Molecular Cell · doi:10.1016/s1097-2765(03)00386-1 · Cited by 689
A transcriptional partner for MAD proteins in TGF-β signalling
Chen, X., Rubock, M. J., & Whitman, M. (1996) · Nature · doi:10.1038/383691a0 · Cited by 684
Pathologic fractures correlate with reduced survival in patients with malignant bone disease
Saad, F., Lipton, A., Cook, R., Chen, Y., Smith, M., & Coleman, R. (2007) · Cancer · doi:10.1002/cncr.22991 · Cited by 667
Nodal Signaling in Vertebrate Development
Schier, A. F. (2003) · Annual Review of Cell and Developmental Biology · doi:10.1146/annurev.cellbio.19.041603.094522 · Cited by 633
To differentiate or not — routes towards metastasis
Brabletz, T. (2012) · Nature Reviews Cancer · doi:10.1038/nrc3265 · Cited by 623
Tumor-induced anorexia and weight loss are mediated by the TGF-β superfamily cytokine MIC-1
Johnen, H., Lin, S., Kuffner, T., Brown, D. A., Tsai, V. W.-W., Bauskin, A. R., Wu, L., Pankhurst, G., Jiang, L., Junankar, S., et al. (2007) · Nature Medicine · doi:10.1038/nm1677 · Cited by 612
Kosinski, C., Li, V. S. W., Chan, A. S. Y., Zhang, J., Ho, C., Tsui, W. Y., Chan, T. L., Mifflin, R. C., Powell, D. W., Yuen, S. T., et al. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0707210104 · Cited by 596
SMAD4-dependent barrier constrains prostate cancer growth and metastatic progression
Ding, Z., Wu, C.-J., Chu, G. C., Xiao, Y., Ho, D., Zhang, J., Perry, S. R., Labrot, E. S., Wu, X., Lis, R., et al. (2011) · Nature · doi:10.1038/nature09677 · Cited by 515
Activin/Nodal signalling maintains pluripotency by controlling Nanog expression
Vallier, L., Mendjan, S., Brown, S., Chng, Z., Teo, A., Smithers, L. E., Trotter, M. W. B., Cho, C. H.-H., Martinez, A., Rugg-Gunn, P., et al. (2009) · Development · doi:10.1242/dev.033951 · Cited by 451
Embryonic and tumorigenic pathways converge via Nodal signaling: role in melanoma aggressiveness
Topczewska, J. M., Postovit, L.-M., Margaryan, N. V., Sam, A., Hess, A. R., Wheaton, W. W., Nickoloff, B. J., Topczewski, J., & Hendrix, M. J. C. (2006) · Nature Medicine · doi:10.1038/nm1448 · Cited by 438
The BMP Inhibitor Coco Reactivates Breast Cancer Cells at Lung Metastatic Sites
Gao, H., Chakraborty, G., Lee-Lim, A. P., Mo, Q., Decker, M., Vonica, A., Shen, R., Brogi, E., Brivanlou, A. H., & Giancotti, F. G. (2012) · Cell · doi:10.1016/j.cell.2012.06.035 · Cited by 430
Lee, J., Son, M. J., Woolard, K., Donin, N. M., Li, A., Cheng, C. H., Kotliarova, S., Kotliarov, Y., Walling, J., Ahn, S., et al. (2008) · Cancer Cell · doi:10.1016/j.ccr.2007.12.005 · Cited by 429
Bone morphogenetic protein 7 in dormancy and metastasis of prostate cancer stem-like cells in bone
Kobayashi, A., Okuda, H., Xing, F., Pandey, P. R., Watabe, M., Hirota, S., Pai, S. K., Liu, W., Fukuda, K., Chambers, C., et al. (2011) · Journal of Experimental Medicine · doi:10.1084/jem.20110840 · Cited by 427
Lonardo, E., Hermann, P. C., Mueller, M.-T., Huber, S., Balic, A., Miranda-Lorenzo, I., Zagorac, S., Alcala, S., Rodriguez-Arabaolaza, I., Ramirez, J. C., et al. (2011) · Cell Stem Cell · doi:10.1016/j.stem.2011.10.001 · Cited by 405
Negative regulation of TGF-β receptor/Smad signal transduction
Itoh, S., & ten Dijke, P. (2007) · Current Opinion in Cell Biology · doi:10.1016/j.ceb.2007.02.015 · Cited by 388
How the Smads regulate transcription
Ross, S., & Hill, C. S. (2008) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2007.09.006 · Cited by 383
Self-citationMcLean, K., Gong, Y., Choi, Y., Deng, N., Yang, K., Bai, S., Cabrera, L., Keller, E., McCauley, L., Cho, K. R., et al. (2011) · Journal of Clinical Investigation · doi:10.1172/jci45273 · Cited by 380
Development of cancer cachexia-like syndrome and adrenal tumors in inhibin-deficient mice.
Matzuk, M. M., Finegold, M. J., Mather, J. P., Krummen, L., Lu, H., & Bradley, A. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.19.8817 · Cited by 374
Singh, A. M., Reynolds, D., Cliff, T., Ohtsuka, S., Mattheyses, A. L., Sun, Y., Menendez, L., Kulik, M., & Dalton, S. (2012) · Cell Stem Cell · doi:10.1016/j.stem.2012.01.014 · Cited by 356
Levy, L., & Hill, C. S. (2005) · Molecular and Cellular Biology · doi:10.1128/mcb.25.18.8108-8125.2005 · Cited by 342
Self-citationNew regulatory mechanisms of TGF-β receptor function
Kang, J. S., Liu, C., & Derynck, R. (2009) · Trends in Cell Biology · doi:10.1016/j.tcb.2009.05.008 · Cited by 328
Sneddon, J. B., Zhen, H. H., Montgomery, K., van de Rijn, M., Tward, A. D., West, R., Gladstone, H., Chang, H. Y., Morganroth, G. S., Oro, A. E., et al. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0606857103 · Cited by 299
Regulation of Bone Morphogenetic Protein Activity by Pro Domains and Proprotein Convertases
Constam, D. B., & Robertson, E. J. (1999) · The Journal of Cell Biology · doi:10.1083/jcb.144.1.139 · Cited by 298
Promiscuity and specificity in BMP receptor activation
Mueller, T. D., & Nickel, J. (2012) · FEBS Letters · doi:10.1016/j.febslet.2012.02.043 · Cited by 289
Extrinsic regulation of pluripotent stem cells
Pera, M. F., & Tam, P. P. L. (2010) · Nature · doi:10.1038/nature09228 · Cited by 287
Postovit, L.-M., Margaryan, N. V., Seftor, E. A., Kirschmann, D. A., Lipavsky, A., Wheaton, W. W., Abbott, D. E., Seftor, R. E. B., & Hendrix, M. J. C. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0800467105 · Cited by 286
Gruber, T. A., Larson Gedman, A., Zhang, J., Koss, C. S., Marada, S., Ta, H. Q., Chen, S.-C., Su, X., Ogden, S. K., Dang, J., et al. (2012) · Cancer Cell · doi:10.1016/j.ccr.2012.10.007 · Cited by 283
Tumor Cell Vasculogenic Mimicry
Seftor, R. E. B., Hess, A. R., Seftor, E. A., Kirschmann, D. A., Hardy, K. M., Margaryan, N. V., & Hendrix, M. J. C. (2012) · The American Journal of Pathology · doi:10.1016/j.ajpath.2012.07.013 · Cited by 282
Daly, A. C., Randall, R. A., & Hill, C. S. (2008) · Molecular and Cellular Biology · doi:10.1128/mcb.01192-08 · Cited by 277
Self-citationFrom developmental disorder to heritable cancer: it's all in the BMP/TGF-β family
Waite, K. A., & Eng, C. (2003) · Nature Reviews Genetics · doi:10.1038/nrg1178 · Cited by 276
Jaeger, E., Leedham, S., Lewis, A., Segditsas, S., Becker, M., Cuadrado, P. R., Davis, H., Kaur, K., Heinimann, K., Howarth, K., et al. (2012) · Nature Genetics · doi:10.1038/ng.2263 · Cited by 276
The dynamic role of bone morphogenetic proteins in neural stem cell fate and maturation
Bond, A. M., Bhalala, O. G., & Kessler, J. A. (2012) · Developmental Neurobiology · doi:10.1002/dneu.22022 · Cited by 259
Mesnard, D., Guzman-Ayala, M., & Constam, D. B. (2006) · Development · doi:10.1242/dev.02413 · Cited by 257
The specificities of small molecule inhibitors of the TGFß and BMP pathways
Vogt, J., Traynor, R., & Sapkota, G. P. (2011) · Cellular Signalling · doi:10.1016/j.cellsig.2011.06.019 · Cited by 256
Candia, A. F., Watabe, T., Hawley, S. H. B., Onichtchouk, D., Zhang, Y., Derynck, R., Niehrs, C., & Cho, K. W. Y. (1997) · Development · doi:10.1242/dev.124.22.4467 · Cited by 256
Pellagatti, A., Jädersten, M., Forsblom, A.-M., Cattan, H., Christensson, B., Emanuelsson, E. K., Merup, M., Nilsson, L., Samuelsson, J., Sander, B., et al. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0610477104 · Cited by 233
Vallet, S., Mukherjee, S., Vaghela, N., Hideshima, T., Fulciniti, M., Pozzi, S., Santo, L., Cirstea, D., Patel, K., Sohani, A. R., et al. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0911929107 · Cited by 230
Katsuno, Y., Hanyu, A., Kanda, H., Ishikawa, Y., Akiyama, F., Iwase, T., Ogata, E., Ehata, S., Miyazono, K., & Imamura, T. (2008) · Oncogene · doi:10.1038/onc.2008.232 · Cited by 230
Differential requirements for Smad4 in TGFβ-dependent patterning of the early mouse embryo
Chu, G. C., Dunn, N. R., Anderson, D. C., Oxburgh, L., & Robertson, E. J. (2004) · Development · doi:10.1242/dev.01248 · Cited by 226
Cancer stem cells: In the line of fire
Alison, M. R., Lin, W.-R., Lim, S. M. L., & Nicholson, L. J. (2012) · Cancer Treatment Reviews · doi:10.1016/j.ctrv.2012.03.003 · Cited by 225
Lombardo, Y., Scopelliti, A., Cammareri, P., Todaro, M., Iovino, F., Ricci–Vitiani, L., Gulotta, G., Dieli, F., de Maria, R., & Stassi, G. (2011) · Gastroenterology · doi:10.1053/j.gastro.2010.10.005 · Cited by 222
Bailey, J. M., Singh, P. K., & Hollingsworth, M. A. (2007) · Journal of Cellular Biochemistry · doi:10.1002/jcb.21509 · Cited by 209
The control of neural stem cells by morphogenic signals
Panchision, D. M., & McKay, R. D. G. (2002) · Current Opinion in Genetics & Development · doi:10.1016/s0959-437x(02)00329-5 · Cited by 206
Buijs, J. T., Rentsch, C. A., van der Horst, G., van Overveld, P. G. M., Wetterwald, A., Schwaninger, R., Henriquez, N. V., ten Dijke, P., Borovecki, F., Markwalder, R., et al. (2007) · The American Journal of Pathology · doi:10.2353/ajpath.2007.070168 · Cited by 200
Bone morphogenetic protein signalling in colorectal cancer
Hardwick, J. C., Kodach, L. L., Offerhaus, G. J., & van den Brink, G. R. (2008) · Nature Reviews Cancer · doi:10.1038/nrc2467 · Cited by 197
A soluble activin Type IIA receptor induces bone formation and improves skeletal integrity
Pearsall, R. S., Canalis, E., Cornwall-Brady, M., Underwood, K. W., Haigis, B., Ucran, J., Kumar, R., Pobre, E., Grinberg, A., Werner, E. D., et al. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0711263105 · Cited by 189
The Harmonies Played by TGF-β in Stem Cell Biology
Oshimori, N., & Fuchs, E. (2012) · Cell Stem Cell · doi:10.1016/j.stem.2012.11.001 · Cited by 189
Auclair, B. A., Benoit, Y. D., Rivard, N., Mishina, Y., & Perreault, N. (2007) · Gastroenterology · doi:10.1053/j.gastro.2007.06.066 · Cited by 187
SPC4/PACE4 regulates a TGFβ signaling network during axis formation
Constam, D. B., & Robertson, E. J. (2000) · Genes & Development · doi:10.1101/gad.14.9.1146 · Cited by 185
ALK1 as an emerging target for antiangiogenic therapy of cancer.
Cunha, S. I., & Pietras, K. (2011) · Blood · doi:10.1182/blood-2011-01-330142 · Cited by 184
Emergence, development and diversification of the TGF-β signalling pathway within the animal kingdom
Huminiecki, L., Goldovsky, L., Freilich, S., Moustakas, A., Ouzounis, C., & Heldin, C.-H. (2009) · BMC Evolutionary Biology · doi:10.1186/1471-2148-9-28 · Cited by 183
BMPs: from bone to body morphogenetic proteins
Wagner, D. O., Sieber, C., Bhushan, R., & Graf, D. (2010) · Zurich Open Repository and Archive (University of Zurich) · doi:10.5167/uzh-46791 · Cited by 182
Lonardo, E., Frias-Aldeguer, J., Hermann, P. C., & Heeschen, C. (2012) · Cell Cycle · doi:10.4161/cc.19679 · Cited by 181
The Regulation and Functions of Activin and Follistatin in Inflammation and Immunity
Hedger, M. P., Winnall, W. R., Phillips, D. J., & de Kretser, D. M. (2011) · Vitamins & Hormones · doi:10.1016/b978-0-12-385961-7.00013-5 · Cited by 177
Cunha, S. I., Pardali, E., Thorikay, M., Anderberg, C., Hawinkels, L., Goumans, M.-J., Seehra, J., Heldin, C.-H., ten Dijke, P., & Pietras, K. (2010) · Journal of Experimental Medicine · doi:10.1084/jem.20091309 · Cited by 177
GDF-15 Contributes to Proliferation and Immune Escape of Malignant Gliomas
Roth, P., Junker, M., Tritschler, I., Mittelbronn, M., Dombrowski, Y., Breit, S. N., Tabatabai, G., Wick, W., Weller, M., & Wischhusen, J. (2010) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-10-0705 · Cited by 175
Liu, I. M., Schilling, S. H., Knouse, K. A., Choy, L., Derynck, R., & Wang, X. (2009) · The EMBO Journal · doi:10.1038/emboj.2008.266 · Cited by 172
Obradovic Wagner, D., Sieber, C., Bhushan, R., Börgermann, J. H., Graf, D., & Knaus, P. (2010) · Science Signaling · doi:10.1126/scisignal.3107mr1 · Cited by 165
Crosstalk between Wnt and bone morphogenic protein signaling: A turbulent relationship
Itasaki, N., & Hoppler, S. (2010) · Developmental Dynamics · doi:10.1002/dvdy.22009 · Cited by 161
Buijs, J. T., van der Horst, G., van den Hoogen, C., Cheung, H., de Rooij, B., Kroon, J., Petersen, M., van Overveld, P. G. M., Pelger, R. C. M., & van der Pluijm, G. (2011) · Oncogene · doi:10.1038/onc.2011.400 · Cited by 150
Kodach, L. L., Jacobs, R. J., Voorneveld, P. W., Wildenberg, M. E., Verspaget, H. W., van Wezel, T., Morreau, H. M., Hommes, D. W., Peppelenbosch, M. P., BRINK, G. R. V. D., et al. (2011) · Gut · doi:10.1136/gut.2011.237495 · Cited by 142
Wrighton, K. H., Lin, X., Yu, P. B., & Feng, X. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m809223200 · Cited by 137
Hu-Lowe, D. D., Chen, E., Zhang, L., Watson, K. D., Mancuso, P., Lappin, P., Wickman, G., Chen, J. H., Wang, J., Jiang, X., et al. (2011) · Cancer Research · doi:10.1158/0008-5472.can-10-1451 · Cited by 130
Endogenous Nodal signaling regulates germ cell potency during mammalian testis development
Spiller, C. M., Feng, C.-W. A., Jackson, A., Gillis, A., Rolland, A. D., Looijenga, L. H. J., Koopman, P. A., & Bowles, J. (2012) · Development · doi:10.1242/dev.083006 · Cited by 130
Hardy, K. M., Kirschmann, D. A., Seftor, E. A., Margaryan, N. V., Postovit, L.-M. M., Strizzi, L., & Hendrix, M. J. C. (2010) · Cancer Research · doi:10.1158/0008-5472.can-10-0705 · Cited by 128
Role of Cripto-1 in Stem Cell Maintenance and Malignant Progression
Bianco, C., Rangel, M. C., de Castro, N. P., Nagaoka, T., Rollman, K., Gonzales, M., & Salomon, D. S. (2010) · American Journal Of Pathology · doi:10.2353/ajpath.2010.100102 · Cited by 124
Integrated epigenomics identifies BMP4 as a modulator of cisplatin sensitivity in gastric cancer
Ivanova, T., Zouridis, H., Wu, Y., Cheng, L. L., Tan, I. B., Gopalakrishnan, V., Ooi, C.-H., Lee, J., Qin, L., Wu, J., et al. (2012) · Gut · doi:10.1136/gutjnl-2011-301113 · Cited by 114
The bright and the dark sides of activin in wound healing and cancer
Antsiferova, M. A., & Werner, S. (2012) · Journal of Cell Science · doi:10.1242/jcs.094789 · Cited by 114
Corre, J., Labat, E., Espagnolle, N., Hébraud, B., Avet‐Loiseau, H., Roussel, M., Huynh, A., Gadelorge, M., Cordelier, P., Klein, B., et al. (2012) · Cancer Research · doi:10.1158/0008-5472.can-11-0188 · Cited by 106
Gronroos, E. C., Kingston, I. J., Ramachandran, A., Randall, R. A., Vizán, P., & Hill, C. S. (2012) · Molecular and Cellular Biology · doi:10.1128/mcb.00231-12 · Cited by 106
Self-citationRole of Cripto-1 during Epithelial-to-Mesenchymal Transition in Development and Cancer
Rangel, M. C., Karasawa, H., de Castro, N. P., Nagaoka, T., Salomon, D. S., & Bianco, C. (2012) · American Journal Of Pathology · doi:10.1016/j.ajpath.2012.02.031 · Cited by 104
Lawrence, M. G., Margaryan, N. V., Loessner, D., Collins, A., Kerr, K. M., Turner, M., Seftor, E. A., Stephens, C. R., Lai, J., BioResource, A., et al. (2011) · The Prostate · doi:10.1002/pros.21335 · Cited by 102
Genomic Determinants of PI3K Pathway Inhibitor Response in Cancer
Weigelt, B., & Downward, J. (2012) · Frontiers in Oncology · doi:10.3389/fonc.2012.00109 · Cited by 102
Serum immunoreactive activin A levels in normal subjects and patients with various diseases
Harada, K., Shintani, Y., Sakamoto, Y., WAKATSUKI, M., Shitsukawa, K., & Saito, S. (1996) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.81.6.8964839 · Cited by 101
Nodal signalling in embryogenesis and tumourigenesis
Quail, D. F., Siegers, G. M., Jewer, M., & Postovit, L.-M. M. (2013) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2012.12.021 · Cited by 99
Spatial regulation of BMP activity
Ramel, M., & Hill, C. S. (2012) · FEBS Letters · doi:10.1016/j.febslet.2012.02.035 · Cited by 99
Self-citationZhang, L., Sun, H., Zhao, F., Lü, P., Ge, C., Li, H., Hou, H., Yan, M., Chen, T., Jiang, G., et al. (2012) · Cancer Research · doi:10.1158/0008-5472.can-12-1013 · Cited by 95
Phosphatases in SMAD regulation
Bruce, D. L., & Sapkota, G. P. (2012) · FEBS Letters · doi:10.1016/j.febslet.2012.02.001 · Cited by 94
Evolution of the TGF-β Signaling Pathway and Its Potential Role in the Ctenophore, Mnemiopsis leidyi
Pang, K., Ryan, J. F., Baxevanis, A. D., & Martindale, M. Q. (2011) · PLoS ONE · doi:10.1371/journal.pone.0024152 · Cited by 93
Epigenetically Reprogramming Metastatic Tumor Cells With An Embryonic Microenvironment
Costa, F. F., Seftor, E. A., Bischof, J. M., Kirschmann, D. A., Strizzi, L., Arndt, K., Bonaldo, M. F., Soares, M. B., & Hendrix, M. J. C. (2009) · Epigenomics · doi:10.2217/epi.09.25 · Cited by 82
Upadhyay, G., Yin, Y., Yuan, H., Li, X., Derynck, R., & Glazer, R. I. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1103441108 · Cited by 75
Identification of NOG as a Specific Breast Cancer Bone Metastasis-supporting Gene
Tarragona, M., Pavlović, M., Estape, A. A., Urosevic, J., Morales, M. L. G., Guiu, M., Planet, E., González‐Suárez, E., & Gomis, R. R. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.355834 · Cited by 75
Rapamycin induces Smad activity in prostate cancer cell lines
van der Poel, H. G., Hanrahan, C. F., Zhong, H., & Simons, J. W. (2003) · Urological Research · doi:10.1007/s00240-002-0282-1 · Cited by 70
Antsiferova, M. A., Huber, M., Meyer, M., Piwko‐Czuchra, A., Ramadan, T., MacLeod, A. S., Havran, W. L., Dummer, R., Hohl, D., & Werner, S. (2011) · Nature Communications · doi:10.1038/ncomms1585 · Cited by 66
Strizzi, L., Hardy, K. M., Margaryan, N. V., Hillman, D. W., Seftor, E. A., Chen, B., Geiger, X. J., Thompson, E. A., Lingle, W. L., Andorfer, C. A., et al. (2012) · Breast Cancer Research · doi:10.1186/bcr3185 · Cited by 66
Galvin, K. E., Travis, E., Yee, D., Magnuson, T., & Vivian, J. L. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.077347 · Cited by 61
Mechanism of osteogenic induction by FK506 via BMP/Smad pathways
Kugimiya, F., Yano, F., Ohba, S., Igawa, K., Nakamura, K., Kawaguchi, H., & Chung, U. (2005) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2005.10.024 · Cited by 59
Activin receptor antagonists for cancer-related anemia and bone disease
Fields, S. Z., Parshad, S., Anne, M., Raftopoulos, H., Alexander, M. J., Sherman, M. L., Laadem, A., Sung, V., & Terpos, E. (2012) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.2013.738666 · Cited by 58
A soluble bone morphogenetic protein type IA receptor increases bone mass and bone strength
Baud’huin, M., Solban, N., Cornwall-Brady, M. R., Sako, D., Kawamoto, Y., Liharska, K., Lath, D., Bouxsein, M., Underwood, K. W., Ucran, J. A., et al. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1204929109 · Cited by 54
Nishimori, H., Ehata, S., Suzuki, H. I., Katsuno, Y., & Miyazono, K. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.353094 · Cited by 49
GDF3 is a BMP inhibitor that can activate Nodal signaling only at very high doses
Levine, A. J., Levine, Z. J., & Brivanlou, A. H. (2008) · Developmental Biology · doi:10.1016/j.ydbio.2008.09.006 · Cited by 48
Nodal Expression and Detection in Cancer: Experience and Challenges
Strizzi, L., Hardy, K. M., Kirschmann, D. A., Ährlund‐Richter, L., & Hendrix, M. J. C. (2012) · Cancer Research · doi:10.1158/0008-5472.can-11-3419 · Cited by 48
Embryonic Protein Nodal Promotes Breast Cancer Vascularization
Quail, D. F., Walsh, L. A., Zhang, G., Findlay, S. D., Moreno, J. C. A., Fung, L. A., Ablack, A. L., Lewis, J. D., Done, S. J., Hess, D. A., et al. (2012) · Cancer Research · doi:10.1158/0008-5472.can-11-3951 · Cited by 40
Cited by
Targeting TGF-β Signaling in Cancer
Colak, S., & ten Dijke, P. (2017) · Trends in cancer · doi:10.1016/j.trecan.2016.11.008 · Cited by 1,003
Prospects for combining targeted and conventional cancer therapy with immunotherapy
Gotwals, P., Cameron, S., Cipolletta, D., Cremasco, V., Crystal, A., Hewes, B., Mueller, B., Quaratino, S., Sabatos-Peyton, C., Petruzzelli, L., et al. (2017) · Nature Reviews Cancer · doi:10.1038/nrc.2017.17 · Cited by 953
Akdis, M., Aab, A., Altunbulakli, C., Azkur, K., Costa, R. A., Crameri, R., Duan, S., Eiwegger, T., Eljaszewicz, A., Ferstl, R., et al. (2016) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2016.06.033 · Cited by 912
Contextual determinants of TGFβ action in development, immunity and cancer
David, C. J., & Massagué, J. (2018) · Nature Reviews Molecular Cell Biology · doi:10.1038/s41580-018-0007-0 · Cited by 851
Tzavlaki, K., & Moustakas, A. (2020) · Biomolecules · doi:10.3390/biom10030487 · Cited by 796
Metadata
- Authors
- Wakefield, L. M., & Hill, C. S.
- Venue
- Nature Reviews Cancer
- Published
- 2013-04-24
- Volume
- 13
- Issue
- 5
- Pages
- 328-341
- ISSN
- 1474-175X (ISSN-L)
- 1474-1768
- OpenAlex
- W1582760249
- Cited by
- 374
- References
- 112
- FWCI
- 2.72
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.